Cefpodoxime 100 mg + Dicloxacillin 500 mg ER Film-Coated Tablet

Cefpodoxime 100 mg + Dicloxacillin 500 mg ER Film-Coated Tablet is a extended-release film-coated tablet formulated with Cefpodoxime 100 mg + Dicloxacillin 500 mg. The active ingredient profile is Cefpodoxime; Dicloxacillin, placing the product in the extended-release antibiotic combination category. The product combines cefpodoxime, a cephalosporin antibiotic, with dicloxacillin, a penicillinase-resistant penicillin. The extended-release designation indicates a modified-release presentation and must be described and used exactly according to the approved product literature. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.